Basilea Pharmaceutica AG Cash Flow Statement

Financials in millions CHF. Fiscal year is January - December.

Millions CHF. Fiscal year is Jan - Dec.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Jun '25 Jun 30, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020
Net Income	72.66	77.59	10.45	12.15	-6.83	-14.72
Depreciation & Amortization	3.37	3.23	3.18	2.7	2.25	2.19
Other Amortization	0.9	0.9	1.74	0.66	1.3	1.3
Loss (Gain) From Sale of Assets	-	1.02	-	-	-0.07	-15.04
Stock-Based Compensation	5.39	5.07	4.76	3.6	4.32	3.53
Other Operating Activities	-2.33	-19.75	-1.57	-0.32	0.39	-0.63
Change in Accounts Receivable	11.44	19.03	5.23	-8.24	-16.25	-2.47
Change in Inventory	8.75	-5.2	-2.17	-1.46	-1.59	-2.62
Change in Accounts Payable	-1.55	5.64	5.66	-10.43	-2.54	6.39
Change in Unearned Revenue	1.75	2.31	-1.23	-1.23	-2.56	-33.63
Change in Other Net Operating Assets	-20.88	-15.48	-11.8	9.64	-10.45	1.56
Operating Cash Flow	79.5	74.36	14.25	7.06	-32.02	-54.13
Operating Cash Flow Growth	671.76%	422.03%	101.89%	-	-	-
Capital Expenditures	-1.56	-1.71	-0.81	-3.14	-0.58	-1.82
Sale of Property, Plant & Equipment	-	-	-	-	0.02	18.33
Divestitures	-	0.78	-	-	-1.6	-
Sale (Purchase) of Intangibles	-0.12	-0.08	-0.22	-0.17	-0.28	-0.44
Investment in Securities	-	-	-	94.95	6.02	-51.02
Other Investing Activities	-	-	-	0	-	-
Investing Cash Flow	-1.69	-1.01	-1.03	91.65	3.58	-34.96
Long-Term Debt Issued	-	-	-	73.88	-	97.09
Long-Term Debt Repaid	-	-15.6	-59.31	-	-	-
Net Debt Issued (Repaid)	-	-15.6	-59.31	73.88	-	97.09
Issuance of Common Stock	0.65	2.46	2.48	4.43	44.11	4.81
Repurchase of Common Stock	-	-	-	-	-4.25	-
Other Financing Activities	-15.15	-0.02	-0.47	-123.55	-23.21	-56.83
Financing Cash Flow	-14.49	-13.16	-57.31	-45.25	16.64	45.07
Foreign Exchange Rate Adjustments	-0.07	0.05	-0.15	0.16	0.5	-0.76
Miscellaneous Cash Flow Adjustments	-	-	-	-	0	-
Net Cash Flow	63.25	60.24	-44.25	53.61	-11.3	-44.79
Free Cash Flow	77.94	72.65	13.43	3.92	-32.6	-55.96
Free Cash Flow Growth	734.87%	440.89%	242.83%	-	-	-
Free Cash Flow Margin	32.99%	34.84%	8.52%	2.65%	-22.01%	-43.84%
Free Cash Flow Per Share	5.62	5.24	1.11	0.33	-2.79	-5.44
Cash Interest Paid	3.25	3.73	9.76	6.33	7.07	4.84
Cash Income Tax Paid	-	-	0.01	0	0.04	0.03
Levered Free Cash Flow	53.05	48.68	8.51	-2.45	-25.21	-46.03
Unlevered Free Cash Flow	54.79	50.8	14.07	3.25	-21.22	-42.48
Change in Working Capital	-0.49	6.29	-4.32	-11.72	-33.39	-30.76

Updated Jun 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.